2011Xiandai yufang yixueRequires access

EFFECTS OF IRBESARTAN ON SERUM LEVEL OF LEPTIN IN PATIENTS WITH ACUTE CEREBRAL INFARCTION

Chen We

Open publisher page 0 citations

Abstract

[Objective] To observe the effects of irbesartan on serum level of leptin in patients with acute cerebral infarction(ACI).[Methods]89 subjects were divided into control group(n = 27),ACI control group(n = 32)and ACI treatment group(n = 30).Patients in both ACI groups were given conventional medicine treatment for 2 weeks,and patients in the ACI treatment group oral irbesartan(150mg/day)for 2 weeks.Blood pressure(Bp),blood lipid,the level of high sensitivity C-reactive protein(hs-CRP)and leptin were measured and the scores of neurological deficit(NDS)were evaluated before and after treatment in all subjects.[Results]Compared to those in the control group,the Bp,TG,Th,LDL and hs-CRP as well as leptin were obviously increased in both ACI groups(P﹤0.01).The hs-CRP and leptin were obviously decreased in both ACI groups after treatment for 2 weeks(P﹤0.05),the changes were significant in the ACI treatment group compare to those in the ACI control group(P﹤0.05).NDS were improved after treatment in both ACI groups.However,lowering of NDS after treatment in the ACI treatment group were more apparent compare to those in the ACI control group(P﹤0.05).[Conclusion]Irbesartan can decrease serum level of leptin,and improve the recovery of neurological function in patients with ACI.

About this research paper

What this paper is about

[Objective] To observe the effects of irbesartan on serum level of leptin in patients with acute cerebral infarction(ACI).[Methods]89 subjects were divided into control group(n = 27),ACI control group(n = 32)and ACI treatment group(n = 30).Patients in both ACI groups were given conventional medicine treatment for 2 weeks,and patients in the ACI treatment group oral irbesartan(150mg/day)for 2 weeks.Blood pressure(Bp),blood lipid,the level of high sensitivity C-reactive protein(hs-CRP)and leptin were measured and the scores of neurological deficit(NDS)were evaluated before and after treatment in all subjects.[Results]Compared to those in the control group,the Bp,TG,Th,LDL and hs-CRP as well as leptin were obviously increased in both ACI groups(P﹤0.01).The hs-CRP and leptin were obviously decreased in both ACI groups after treatment for 2 weeks(P﹤0.05),the changes were significant in the ACI treatment group compare to those in the ACI control group(P﹤0.05).NDS were improved after treatment in both ACI groups.However,lowering of NDS after treatment in the ACI treatment group were more apparent compare to those in the ACI control group(P﹤0.05).[Conclusion]Irbesartan can decrease serum level of leptin,and improve the recovery of neurological function in patients with ACI.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

[Objective] To observe the effects of irbesartan on serum level of leptin in patients with acute cerebral infarction(ACI).[Methods]89 subjects were divided into control group(n = 27),ACI control group(n = 32)and ACI treatment group(n = 30).Patients in both ACI groups were given conventional medicine treatment for 2 weeks,and patients in the ACI treatment group oral irbesartan(150mg/day)for 2 weeks.Blood pressure(Bp),blood lipid,the level of high sensitivity C-reactive protein(hs-CRP)and leptin were measured and the scores of neurological deficit(NDS)were evaluated before and after treatment in all subjects.[Results]Compared to those in the control group,the Bp,TG,Th,LDL and hs-CRP as well as leptin were obviously increased in both ACI groups(P﹤0.01).The hs-CRP and leptin were obviously decreased in both ACI groups after treatment for 2 weeks(P﹤0.05),the changes were significant in the ACI treatment group compare to those in the ACI control group(P﹤0.05).NDS were improved after treatment in both ACI groups.However,lowering of NDS after treatment in the ACI treatment group were more apparent compare to those in the ACI control group(P﹤0.05).[Conclusion]Irbesartan can decrease serum level of leptin,and improve the recovery of neurological function in patients with ACI.

Key concepts: Irbesartan, Medicine, Leptin, Internal medicine, Blood lipids, Gastroenterology, Blood pressure, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
EFFECTS OF IRBESARTAN ON SERUM LEVEL OF LEPTIN IN PATIENTS WITH ACUTE CEREBRAL INFARCTION — Research Paper | ScholarLens